| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.054 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |